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ABSTRACT. MnCl2, FeCl3, Ru(DMSO)4Cl2, CoCl2, NiCl2, PdCl2, CuCl2, AgNO3, CdCl2 and HgCl2 complexes 
of 2-(5-nitro-1H-benzimidazol-2-yl)-4-bromophenol (HL) were synthesized and characterized. The structures of 
the complexes were confirmed on the basis of elemental analysis, TGA, molar conductivity and magnetic moment 
measurements, FT-IR, far-IR, FT-Raman, UV-Visible, NMR and fluorescence spectroscopy. According to the 
analytical and spectral data, the ligand acted as bidentate, via the imine nitrogen and the phenolate oxygen atoms 
towards to the metal ions except the Ag(I). The complexes were screened for in vitro antibacterial activities 
against S. aureus, S. epidermidis, E. coli, K. pneumoniae, P. aeruginosa, P. mirabilis and for antifungal activity 
against C. albicans. Ciprofloxacin and fluconazole were used as reference for antibacterial and antifungal 
activities of the complexes, respectively. In most cases, the complexes tested showed considerable activity on S. 
aureus especially, which is a Gram positive bacterium. In addition, the Hg(II) and Ag(I) complexes were found to 
have superior activity toward all of the microorganisms whereas the Pd(II) and Cd(II) complexes showed 
considerably antimicrobial effect on S. aureus and C. albicans selectively. 
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INTRODUCTION 
 
It is known that biological metal ions play key roles in the structural organization and activation 
of certain enzymes, which are involved in the transfer of genetic information from DNA, 
leading to the synthesis of specific proteins. Transition metal complexes have attracted 
attentions of inorganic, metallo-organic as well as bio-inorganic chemists because of their 
extensive applications in wide ranging areas from material to biological sciences [1]. 
Antimicrobial activity of some 2-(1H-benzimidazol-2-yl)-phenol derivatives and their metal 
complexes were investigated in detail against some microorganisms. In our previous studies, we 
found that various benzimidazolyl-phenol derivatives and some of their complexes showed 
antimicrobial activity against several microorganisms [2-6]. For instance, 2-(5-H/Me/Cl/NO2-
1H-benzimidazol-2-yl)-4-Br/NO2-phenols were effective especially on S. aureus; their Ag(I) 
and Hg(II) complexes showed high antimicrobial activity toward six bacteria in the study [2]. 
The Fe(III) complexes of 2-(5-H/Me-1H-benzimidazol-2-yl)-4-Br/NO2-phenols exhibited 
considerable activity against S. aureus and S. epidermidis [3]. 2-(5-H/Me/Cl-1H-benzimidazol-
2-yl)-phenols and their Fe(III) complexes showed considerable activity on some bacteria and 
fungi [4]. It was reported that the Co(II) and Ni(II) chelates of 2-(1H-benzimidazol-2-yl)-phenol 
have antifungal activity against A. alternata and A. niger [5, 6].  
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2-Methoxy-6-(5-H/Me/Cl/NO2-1H-benzimidazol-2-yl)-phenols and their some transition 
metal complexes were synthesized and characterized. Some ligands and Cu(II) and Zn(II) 
complexes showed antibacterial activity against Gram positive bacteria [7]. It was reported that 
4-methoxy-2-(1H-benzimidazol-2-yl)-phenol and its Ag(I) and Cu(II) complexes are effective 
on S. epidermidis, S. aureus and B. subtilis. Also, 4-methoxy-2-(5-methyl/chloro-1H-
benzimidazol-2-yl)-phenols showed antibacterial activity toward S. aureus [8]. Ag(I) and Zn(II) 
complexes of 2-methyl-6-(1H-benzimidazol-2-yl)-phenol showed antibacterial effect toward K. 
pneumoniae, S. epidermidis and S. aureus bacteria whereas the ligand itself had no any activity 
[9]. 2-(5-H/Me/F/Cl/NO2-1H-benzimidazol-2-yl)-benzene-1,4-diols (HLX: x = 1-5) and HL1 
complexes with Fe(NO3)3, Co(NO3)2, Ni(NO3)2, Cu(NO3)2, Zn(NO3)2 showed considerable 
antimicrobial activity [10]. Pd(II), Ag(I) and Au(III) complexes of 4-(1H-benzimidazol-2-yl)-
benzene-1,3-diol showed considerable antibacterial and antifungal activity whereas the ligand 
itself has no any activity [11].   
Spectral characterizations and antibacterial effect of 2-(5-H/Cl/Me/NO2-1H-benzimidazol-2-
yl)-4-Me/Br-phenols (HL1–HL5) and their some transition metal complexes were reported by us: 
while HL1 ligand has considerable antibacterial activity on B. cereus only; it’s Ag(I) complex 
show antibacterial effect toward almost to the all bacteria. HL5 and [Zn(L5)2]∙HClO4 exhibit 
considerable high antibacterial activity toward K. pneumoniae, B. cereus, S. epidermidis and B. 
subtilis [12]. 
3-(5-H/Me/Cl/NO2-1H-benzimidazol-2-yl)-benzene-1,2-diols (HLX: x = 1-4) ligands and 
HL3 complexes with Fe(NO3)3, Cu(NO3)2, Co(NO3)2, Zn(NO3)2 have been synthesized and 
characterized. HL1, HL2, HL3 and [Cu(L3)2]∙(H2O)2 show considerable antimicrobial activity 
toward S. epidermidis and C. albicans [13]. 
Coordination compounds exhibit different characteristic properties depend on the metal ion 
that they are bonded [14]. These metal complexes have extensive applications in various fields 
of human interest on the basis of nature of the metal as well as the type of ligand [15, 16]. 
Chelation or complexation shows more potent antibacterial effect against some microorganisms 
than the respective drug [17-19]. We reported that 2-(5-nitro-1H-benzimidazol-2-yl)-4-
bromophenol (HL) ligand and its Zn(NO3)2, Fe(NO3)3 and Cu(NO3)2 complexes showed strong 
antibacterial activity toward S. aureus and S. epidermidis [20, 21]. In this study, we aimed to 
synthesize the new transition metal complexes of HL (Figure 1) with MnCl2, FeCl3, 
Ru(DMSO)4Cl2, CoCl2, NiCl2, PdCl2, CuCl2, AgNO3, CdCl2 and HgCl2 and to investigate their 
structural characteristics and antimicrobial activities toward six bacteria and one fungi, C. 
albicans.  
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Figure 1. Structure of the ligand. 
EXPERIMENTAL 
Chemistry and apparatus 
 
All chemicals and solvents were of reagent grade from Sigma-Aldrich, Merck, Alfa Easer, Carlo 
Erba and Acros Organics and they were used without further purification.  
Analytical data were obtained with a Thermo Finnigan Flash EA 1112 analyzer. Melting 
points were determined using an Electrothermal melting-point apparatus. Molar conductivity of 
the complexes was measured on a WTW Cond315i conductivity meter in DMF at 25 °C. 1H-
NMR spectra were run on a Varian Unity Inova 500 NMR spectrometer. The residual DMSO-d6 
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signal was also used as an internal reference. FT mid-IR and far-IR spectra were recorded on a 
Bruker Optics Vertex 70 spectrometer using Attenuated Total Reflection (ATR) techniques 
between 100 and 4000 cm–1. The FT-Raman spectra were also recorded in the same instrument 
with a R100/R RAMII Raman module equipped with Nd:YAG laser source operating at 1064 
nm line with 200 mW power and a spectral resolution of  ±2 cm–1. UV-Visible spectra was 
performed on a Perkin Elmer Lambda 25 UV/Visible Spectrometer in MeOH. Fluorescence 
spectra were performed on a Shimadzu RF-5301 PC Spectrofluorophotometer. 
Thermogravimetric studies were made on a TG-60WS Shimadzu, with a heating rate of 10 
°C/min and air flowing at the rate of 50 mL/min. Magnetic measurements of the paramagnetic 
complexes were carried out on MK1 Sherwood Scientific apparatus at room temperature by 
Gouy’s method. Diamagnetic corrections were made using Pascal’s constants.  
 
Synthesis of the ligand 
 
The ligand was prepared according to the literature procedures [22, 23]. 2-Hydroxy-5-
bromobenzaldehyde (2.01 g, 10 mmol) reacted with an equivalent amount of NaHSO3 (1.04 g, 
10 mmol) in ethanol (25 mL) at room temperature for 4 h. The mixture was treated with 4-nitro-
1,2-phenylenediamine (1.53 g, 10 mmol) in dimethylformamide (15 mL) and gently refluxed for 
2 h. The reaction mixture was then poured into iced water (500 mL) and then a precipitate was 
formed. It was filtered and crystallized from ethanol. Yield: 2.04 g (61%). 
 
Synthesis of the complexes 
 
The metal complexes were synthesized by treating an ethanolic solution of the ligand with 
an equimolar amount of metal salts under reflux about 2 h except the Ag(I) complex.  
 
[Mn(L)2(H2O)]∙H2O. Equimolar amount of the ligand (167 mg, 0.5 mmol) and MnCl2∙6H2O 
(117 mg, 0.5 mmol) were mixed in ethanol (20 mL). This mixture was refluxed for 2 h and then 
filtered. After 2 days, a brown precipitate was formed in the filtrate. It was filtered and dried at 
room temperature. Yield: 155 mg (65%). 
 
[Fe(L)2(OH)(H2O)]∙2H2O. 135 mg of FeCl3∙6H2O (0.5 mmol) were added to the ligand (167 
mg, 0.5 mmol) solution in ethanol (20 mL). The black mixture was refluxed for 2 h and then 
filtered. In the filtrate, a black precipitate was formed after 3-4 days staying at room 
temperature. It was filtered and dried at room temperature. Yield: 156 mg (68%). 
 
[Ru(L)2(DMSO)2Cl]∙4H2O. 242 mg of Ru(DMSO)4Cl2 (0.5 mmol) were added to the ligand 
(167 mg, 0.5 mmol) solution in ethanol (20 mL). The black mixture was refluxed for 2 h and 
then filtered. In the filtrate, a black precipitate was formed after a week staying at room 
temperature. It was filtered and dried at room temperature. Yield: 180 mg (68%).   
 
[Co(HL)Cl2(H2O)2]∙2H2O. 119 mg of CoCl2∙6H2O (0.5 mmol) were added to the ligand (167 
mg, 0.5 mmol) solution in ethanol (20 mL). The mixture was refluxed for 2 h, and a slightly 
turbid solution was formed. It was filtered after cooling and left at room temperature. A brown 
precipitate was obtained from the filtrate after 2 days. It was filtered and dried at room 
temperature. Yield: 185 mg (69%). 
 
[Ni(HL)Cl2(H2O)2]∙4H2O. 120 mg of NiCl2∙6H2O (~0.5 mmol) were added to the ligand (167 
mg, 0.5 mmol) solution in ethanol (20 mL). The mixture was refluxed for 2 h, and a slightly 
turbid solution was formed as in the Co(II) complex. The brown colored precipitate formed in 
the filtrate after 3 days was filtered and dried at room temperature. Yield: 175 mg (70%).  
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[Pd(HL)2Cl2]. 88.5 mg of PdCl2 (0.5 mmol) and 74.6 mg of KCl (1.0 mmol) were dissolved in 
ethanol (5 mL) and this solution was added to the ligand (167 mg, 0.5 mmol) solution in ethanol 
(15 mL). The mixture was refluxed for 2 h and filtered after cooling to room temperature. The 
claret red precipitate was filtered off, dried at room temperature. Yield: 195 mg (75%).  
 
[Cu(L)2(EtOH)2]∙H2O. 86 mg of CuCl2∙2H2O (0.5 mmol) were added to the ligand (167 mg, 0.5 
mmol) solution in ethanol (20 mL). The mixture was refluxed for 2 h and a slightly turbid 
solution was obtained. The brown colored precipitate formed in the filtrate in 2 days was filtered 
and dried at room temperature. Yield: 160 mg (74%).  
 
[Ag(HL)(L)]∙H2O. 85 mg of AgNO3 (0.5 mmol) were added to the equimolar ligand solution in 
ethanol (20 mL). The mixture was stirred overnight at room temperature. A slightly turbid 
solution was formed and filtered. The filtrate was stayed at room temperature. After 2 days a 
dirty white precipitate was formed. It was filtered and dried at room temperature. Yield: 121 mg 
(64%).  
 
[Cd(HL)(L)Cl]∙H2O. 101 mg of CdCl2∙H2O (0.5 mmol) were added to the equimolar ligand 
solution in ethanol (20 mL). The mixture was refluxed for 2 h, and a slightly turbid solution was 
formed. It was filtered after cooling. The dirty white crystals were formed in the filtrate after 3 
days at room temperature. It was filtered and dried at room temperature. Yield: 165 mg (67%). 
 
[Hg(HL)Cl2]∙2H2O. This complex was prepared in a similar manner to [Cd(L)2]∙H2O complex. 
136 mg of HgCl2 (0.5 mmol) was added to the equimolar ligand solution. Yield: 275 mg (63%). 
  
The analytical and physicochemical data of the complexes are presented in Table 1. 
 
Determination of antimicrobial activity 
 
Antimicrobial activity against Staphylococcus aureus ATCC 6538, Staphylococcus epidermidis 
ATCC 12228, Escherichia coli ATCC 8739, Klebsiella pneumoniae ATCC 4352, Pseudomonas 
aeruginosa ATCC 27853, Proteus mirabilis ATCC 14153 and Candida albicans ATCC 10231 
were determined by the microbroth dilutions technique following the Clinical and Laboratory 
Standards Institute (CLSI) recommendations [24, 25]. Mueller-Hinton broth (MHB) (Difco, 
Detroit, MI, USA) for bacteria, RPMI-1640 medium buffered to pH 7.0 with MOPS (Sigma, St. 
Louis, MO, USA) for yeast strain was used as the test medium. Serial two-fold dilutions ranging 
from 5000 g/mL to 2.4 g/mL were prepared in MHB. The inoculum was prepared using a 4–6 
h broth culture of each bacteria and 24 culture of yeast strains adjusted to a turbidity equivalent 
to a 0.5 McFarland standard, diluted in broth media to give a final concentration of 5×105 
cfu/mL for bacteria and 0.5×103 to 2.5×103 cfu/mL for yeast in the test tray. The trays were 
covered and placed in plastic bags to prevent evaporation. The trays containing MHB were 
incubated at 35 °C for 18–20 h and the trays containing RPMI-1640 medium were incubated at 
35 ºC for 46–50 h. The minimum inhibitory concentrations (MIC) were defined as the lowest 
concentration of compound giving complete inhibition of visible growth. As control, 
antimicrobial effects of dimethylsulfoxide (DMSO) were investigated against test 
microorganisms. Ciprofloxacin and fluconazole were used to verify the standardization of the 
micro-dilution test procedure as reference antimicrobials for bacteria and yeast, respectively. 
According to values of the controls, the results were evaluated. The MIC values of the 
ciprofloxacin and fluconazole are within the accuracy range in CLSI throughout the study [26]. 
The experiments were performed in duplicate. 
RESULTS AND DISCUSSION 
 
The analytical data and physical properties of the complexes are summarized in Table 1.  
Spectral characterization and antimicrobial activity of some transition metal complexes  
Bull. Chem. Soc. Ethiop. 2019, 33(3) 
455
Table 1. The analytical data and physical properties of the ligand and the complexes. 
 
Compound 
Elemental analysis:  
found (calcd) % 
m.p. 
°C 
 M Λ 
 
Color 
C H N 
HL 
C13H8BrN3O3 
46.41  
(46.73) 
2.62  
(2.46) 
12.81  
(12.66) 
277 0 - 
Dark  
yellow 
[Mn(L)2(H2O)]∙H2O  
C26H18Br2N6O8Mn 
40.74 
(41.24) 
2.56 
(2.40) 
10.35 
(11.10) 
>35
0 
4.00 58 Brown 
[Fe(L)2(OH)(H2O)]∙2H2O  
C26H21Br2N6O10Fe 
39.48 
(39.37) 
3.01 
(2.67) 
10.14 
(10.60) 
>35
0 
5.80 43 Black 
[Ru(L)2(DMSO)2Cl]∙4H2O
1 
C30H34Br2ClN6O12S2Ru 
35.09 
(34.95) 
3.13 
(3.32) 
7.87 
(8.15) 
>35
0 
1.42 13 Black 
[Co(HL)Cl2(H2O)2]∙2H2O   
C13H16BrCl2CoN3O7 
29.42 
(29.13) 
2.71 
(3.01) 
7.42 
(7.84) 
>35
0 
4.66 36 
Dark 
brown 
[Ni(HL)Cl2(H2O)2]∙4H2O
2 
C13H20BrCl2N3O9Ni 
26.12 
(27.31) 
3.94 
(3.53) 
6.85 
(7.35) 
>35
0 
3.14 123 
Dark 
brown 
[Pd(HL)2Cl2] 
C26H16Br2Cl2N6O6Pd 
37.27 
(36.93) 
2.11 
(1.91) 
9.67 
(9.94) 
>35
0 
0 18 
Claret 
red 
[Cu(L)2(EtOH)2]∙H2O  
C28H22Br2N6O8Cu 
41.99 
(42.36) 
3.18  
(2.79) 
10.73 
 (10.59) 
>35
0 
1.75 52 Brown 
[Ag(HL)(L)]∙H2O  
C26H17Br2N6O7Ag 
38.96 
(39.37) 
2.38 
(2.16) 
10.25 
(10.60) 
158 0 67 
Dirty 
white 
[Cd(HL)(L)Cl]∙H2O  
C26H17Br2ClN6O7Cd 
38.41 
(37.48) 
2.26 
(2.06) 
10.22 
(10.09) 
292 0 10 
Dirty 
white 
[Hg(HL)Cl2]∙2H2O 
C13H12BrCl2N3O5Hg 
23.92 
(24.33) 
1.73 
(1.89) 
6.27 
(6.55) 
221 0 31 
Dirty 
white 
 M, magnetic moment, BM; Λ, molar conductivity, 1cm2mol1 (25±1ºC) in DMF. 1S%: 6.09 (6.22). 2Ni%: 7.89 
(7.35). 
 
General properties  
 
HL is a bidentate, monodeprotonable and chelating ligand. Spectral characterization of HL and 
its Fe(NO3)3, Cu(NO3)2 and Zn(NO3)2 complexes were reported in previous studies [12, 13]. In 
this study, MnCl2, FeCl3, Ru(DMSO)4Cl2, CoCl2, NiCl2, PdCl2, CuCl2, AgNO3, CdCl2 and 
HgCl2 complexes of the ligand (HL) were synthesized and characterized. Mn(II) Fe(III), 
Ru(III), Pd(II), Cu(II), Ag(I) and Cd(II) complexes have 1:1 M:L ratio whereas the Co(II), 
Ni(II) and Hg(II) complexes are 1:2 (bis-type). 
  According to the analytical data, the ligand is monodeprotonated through the phenolic OH 
hydrogen atom in most of the complexes. Molar conductivity data shows that the MnCl2, FeCl3, 
Ru(DMSO)4Cl2, CoCl2, CuCl2, CdCl2 and HgCl2 complexes are non-ionic (molar conductivities 
are in the 10-58 1cm2mol1 range). The Ag(I) complex is a 1:1 ionic complex (67 
1cm2mol1) while the Ni(II) complex has 1:2 ionic character (123 1cm2mol1) [27].  
The room temperature effective magnetic moment value of the Fe(III) complex, 5.80 BM, 
can be considered as indicating stabilization of the species having high ferric spin (s = 5/2) state. 
The magnetic moment value of the Cu(II) complex (1.75 BM) are very closer to the expected 
value (1.73 BM) for a simple mononuclear Cu(II) complex. The magnetic moment value of 
Mn(II) complex, 4.00 BM, may be accepted indicating stabilization of the species having 
intermediate spin (s = 3/2) state for d5 ion and can be taken into account as an indication for a 
five-coordinated structure and square pyramidal geometry due to theoretical magnetic moment 
value of three unpaired electrons is 3.88 BM (d5 ion in square pyramidal environment: dxz
2 dyz
1 
dxy
1 dz2
1) [28, 29].  
The magnetic moment value of Co(II) complex, 4.66 BM, is in the expected range for 
octahedral complexes having high-spin state [30]. The magnetic moment value of the Ni(II) 
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complex (3.14 BM) can be considered as evidence showing a distorted octahedral geometry for 
[Ni(HL)Cl2(H2O)2]∙4H2O [31, 32]. 
Surprisingly, the ruthenium complex shows paramagnetic characteristic with a magnetic 
moment value 1.42 BM, although Ru(II), is a d6 system, was used for complex preparation. This 
can be interpreted that ruthenium undergoes a one-electron oxidation during the course of the 
complexation reaction and in view of the ruthenium(III)/ruthenium(II) reduction potential 
displayed by this complex, aerial oxygen appears to have served as the oxidant. It can be 
interpreted that the magnetic moment value of Ru(III) complex corresponds to one unpaired 
electron for d5 electronic configuration despite it is lower than the expected value (1.71 BM) 
[33]. It can be proposed capped octahedron or pentagonal bipyramid geometry for Ru(III) 
complex. 
Thermal analysis 
The major features of the thermal analysis of the complexes are summarized in Table 2. TGA 
curves of the Mn(II), Ru(III), Co(II), Ni(II) and Cd(II) complexes are shown in Figure 2. The 
samples of the complexes were heated from room temperature up to 800 °C. Thermal analysis 
results exhibited the valuable information about the water coordination state of the complexes. 
Thermal degradation of complexes occurred in three stages. At the first stage, uncoordinated 
lattice water was lost through evaporation from 50 to 100 °C (Table 2, first column). At the 
second stage, the coordinated water molecules are removed from all the complexes except Pd(II) 
complex at temperatures between 100 and 150 °C (Table 2, second column) [34, 35]. In all 
complexes, weight losses observed above 250 °C can be explained in terms of cleavage of the 
Br and nitro groups and also as decomposition of the anions.  Above 350 ºC, all other organic 
parts of complexes are oxidized to carbon dioxide, nitrogen oxides and water (third stage). The 
decomposition reactions result in the formation of metal oxides.   
 
Table 2. TGA data of the complexes (thermal decomposition). 
 
Temperature (°C) → 100     150      200     250     300     350     400 450 500 550 600 650 700 
Complex Weight loss (%) 
[Mn(L)2(H2O)]∙H2O 3.2 4.8 5.9 9.0 12.0 21.2 25.4 48.0 58.7 67.1 80.4 90.6 91.8 
Fe(III) complexa 4.2 4.5 7.6 8.1 8.8 9.7 74.6 88.5 90.4 90.4 90.4 90.4 90.4 
Ru(III) complexb 6.5 7.6 8.9 9.3 16.1 22.4 31.3 64.7 81.0 82.4 83.4 84.5 84.5 
Co(II) complexc 6.5 9.5 11.1 14.5 17.2 20.6 26.6 56.6 64.0 73.5 84.3 84.9 84.9 
Ni(II) complexd 4.9 7.1 13.2 16.6 20.3 25.0 27.0 37.1 47.2 63.4 67.8 79.3 83.3 
[Pd(HL)2Cl2] 1.1 3.6 10.0 16.4 20.8 24.0 35.4 45.6 50.0 58.9 69.0 76.1 84.5 
[Cu(L)2(EtOH)2]∙H2O 2.9 8.5 9.6 10.9 14.6 15.3 57.2 80.7 82.1 86.1 89.1 91.2 91.2 
[Ag(HL)(L)]∙H2O
e 2.2 2.9 4.5 9.9 16.0 19.4 22.1 26.5 31.5 37.9 44.0 53.4 61.5 
[Cd(HL)(L)Cl]∙H2O
f 1.9 2.7 3.6 5.75 9.3 11.9 15.0 19.4 27.3 33.2 45.7 69.9 93.7 
[Hg(HL)Cl2]∙2H2O 5.3 7.1 12.7 35.8 38.8 44.8 48.2 52.7 56.8 65.3 74.3 88.9 100 
 a[Fe(L)2(OH)(H2O)]∙2H2O; 
b[Ru(L)2(DMSO)2Cl]∙4H2O; 
 c[Co(HL)Cl2(H2O)2]∙2H2O; 
d[Ni(HL)Cl2(H2O)2]∙4H2O;
 e: 
750 °C: 64.5; 800 °C: 69.3; 850 °C: 84.5;  f: 750 °C: 98.5; 800 °C: 100. 
TGA data are compatible with the suggested structures of the complexes. Molecular weight 
ratio of the amount of metal oxide show very good agreement for the proposed structures 
according to the TGA data.  The weight loss is 100% in the Hg(II) and Cd(II) complexes around 
700 and 800 °C, respectively (Figure 3). This anomaly is due to the volatility in the second 
phase of decomposition [36, 37] (HgO and CdO decompose around 500 °C and metallic 
mercury vapors at 357 °C, and metallic Cd vapors at 767 °C).  
Vibrational spectroscopy 
The FT-IR (mid-IR and far-IR) and FT-Raman spectral data of the compounds are given in 
Table 3. In addition, far-IR spectra of the HL, Ru(III) and Cu(II) complexes in Figure 3 and FT-
Raman spectra of HL and Cd(II) complex are given in Figure 4.  
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Interpretation of the Raman, mid
the complexes relative to that of free ligand.
frequencies of the ligand exhibit only a medium broad ban
caused by double intramolecular hydrogen bonding between the phenoxyl hydrogen atom and 
one of the imine nitrogen atom [4, 22, 38, 39]. 
complexation indicating deprotonation and subsequent involvement of the phenoxyl group in 
metal coordination in the Mn(II), Fe(III), Ru(III), Cu(II) and Cd(II) complexes [40]. 
phenolic oxygen atom coordination
at a lower frequency region ca. 535 cm
medium broad bands between 3300 and 3400 cm
presence of the coordinated and uncoordinated water molecules.
Figure 2. TGA curves of the Mn(II), Ru(III), Co(II), Ni(II) and Cd(II) complexes
 
The characteristic (C–H) and 
complexes are observed in the wave region 
3), respectively, particularly in the Raman spectra of the compounds. The C
stretching frequencies are expected to appear at between 1631 and 1594 cm
characteristics for the ligand a
ligand and the complexes in this region support the formation of new complexes. The 
coordination of imine nitrogen atom could also be confirmed by appearance of two new bands 
around 400 and 200 cm1 may be assignable to ν(M
42]. Similar vibrational changes are detected in the Raman spectra (Table 3).
the ligand and the complexes, the strong or medium bands at the ranges 1514
1341 cm1 are assigned to the symmetric and asymmetric 
stretching vibration is seen at the range 525
NMR spectroscopy 
1H-NMR spectral data of the ligand and the diamagnetic complexes and their assignments are 
present in Table 4. 1H-NMR spectra of the ligand were reported in our previous study [20]. In 
the HL spectra, two broad singlets are observed for the NH and OH proton
Bull. Chem. Soc. Ethiop. 2019, 33(3) 
-IR and far-IR spectra is based on changes in the spectra of 
 The characteristic (O–H) and (N–H) vibration 
d at 3327 cm1 in the IR spectra, 
This band is changed significantly upon metal 
 could also be supported by the appearance of medium bands 
1, assignable to ν(M–OC) vibration frequencies. 
1 in the complexes strongly support the 
 
 
. 
(C–H) modes of ring residues in the ligand and the 
between 31323076 cm1 and 822–723 cm1 (Table 
C and C=N 
1 with their own 
nd the complexes. Specific differences between spectra of the free 
–N) and δ(M–N) vibration modes [8, 41, 
 In the IR spectra of 
–1524 and 
(NO2), respectively. The C
–554 cm1 as medium bands [43]. 
s at 13.41 and 12.37 
 457
The 
The 
1308–
–Br 
458
ppm, respectively. The OH proton appears at higher ppm values than the expected because of 
the hydrogen bonding between C=N nitrogen and OH hydrogen atoms [10, 22].
NH protons show considerable changes in NMR spectra on comp
connected with the coordination of the phenolic OH oxygen atom and removing the hydrogen 
bonding mentioned above. 
 
Figure 3. Far-IR spectra of the ligand and Ru(III) and Cu(II) complexes.
 
Figure 4. FT-Raman spectra of 
 
Table 3. The FT-IR (mid- and far
(frequencies, cm–1). 
 
Compound 
HL 3327 m,br, 3085 m, 1630 m, 1597 m, 1583 m, 
1518 s, 1483 s, 1339 s, 1322 s, 1249 s, 
970 m, 817 m, 737 m, 633 m, 554 m, 468 w, 394 
m, 356 m, 323 m, 224 w, 144 w, 127 w, 96 m
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 The OH and 
lexation. This should be 
 
 
 
HL (a) and its Cd(II) complex (b). 
-IR) and Raman spectral data of the ligand and the complexes 
FT-IR  FT-Raman 
1065 m, 
 
3074 m, 2978 w, 2887 w, 1630 
m, 1605 m, 1526 m, 1442 m, 
1375 w, 1337 s, 1312 sh, 1269 
m, 1244 m, 1130 w, 1060 m, 
965 m, 867 w, 840 m, 793 w, 
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690 w, 633 w, 357 w, 270 w, 
202 w, 145 m, 72 s 
[Mn(L)2(H2O)]∙H2O 3346 m, 3080 m, 2907 w,br, 1631 m, 1603 m, 
1522 m, 1478 m, 1438 m, 1329 s, 1256 m, 1095 m, 
1068 m, 822 m, 737 m, 693 m, 633 m, 544 m, 460 
m, 382 w, 354 m, 265 w, 207 m, 135 m, 107 m, 87 
m 
Could not be obtained 
[Fe(L)2(OH)(H2O)] 
∙2H2O 
(A very broad band at 3500-2500 cm1 range) 3084 
m,br, 3067 m,br, 2927 m,br, 2855 m,br, 1631 m, 
1603 m, 1522 m, 1470 m, 1417 m, 1341 s, 1249 m, 
1176 m, 878 m, 822 s, 733 m, 652 m, 624 m, 540 
m, 427 m, 375 m, 325 m, 281 m, 225 m, 153 m, 78 
m 
1592 m, 1533 m, 1478 m, 1364 
w, 1303 s, 1245 m, 878 m, 835 
w, 713 m, 656 s, 478 w, 421 m, 
370 m, 284 m, 190 w, 129 m 
[Ru(L)2(DMSO)2Cl
] ∙4H2O 
3390 m,br, 3092 m,br, 3011 m,br, 2923 w, 1627 m, 
1594 m, 1518 m, 1469 m, 1417 m, 1337 s, 1293 m, 
1240 m, 1071 m, 1015 m, 990 m, 878 m, 822 s, 
736 m, 692 m, 652 m, 535 m, 414 m, 375 m, 299 
m, 246 m, 166 m, 143 m, 106 s, 82 w. 
Could not be obtained 
[Co(HL)Cl2(H2O)2] 
∙2H2O 
3382 m,br, 3180 m,br, 3129 m,br, 2927 w,br, 1627 
m, 1599 m, 1518 m, 1474 m, 1417 m, 1337 s, 1249 
m, 1071 m, 982 m, 878 m, 818 s, 737 m, 692 m, 
632 m, 544 m, 467 w, 451 m, 393 m, 321 m, 276 
m, 208 m, 185 m, 149 s, 116 m 
Could not be obtained 
[Ni(HL)Cl2(H2O)2]∙ 
4H2O 
3491 m, 3382 m, 3350 m,br, 3080 m,br, 2923 m,br, 
1627 sh, 1603 m, 1519 m, 1478 m, 1337 m, 1285 
m, 1245 m, 1139 m, 1064 m, 882 m, 818 s, 729 m, 
693 m, 564 m, 544 m, 471 m, 427 w, 393 m, 278 
m, 221 m, 158 m, 116 m, 91 m 
3074 w, 2811 w, 1602 s, 1556 
m, 1520 m, 1448 m, 1330 m, 
1290 m, 1253 m, 1063m, 965 
w, 839 m, 764 w, 700 w, 629 
w, 75 m 
[Pd(HL)2Cl2] 3411 m, 3113 m, 2937 w,br, 1626 m, 1604 m, 
1515 m, 1470 s, 1381 m, 1314 m, 1252 m, 1146 m, 
1068 m, 816 s, 738 m, 693 m, 568 m, 525 m, 
428m, 333 m, 268 w, 192 m, 159 m, 114 sh, 100 m 
Could not be obtained 
[Cu(L)2(EtOH)2]∙ 
H2O 
3366 m,br, 3328 m,br, 3132 m, 1629 m, 1604 m, 
1537 m, 1515 m, 1473 m, 1311 m, 1252 m, 1149 
m, 1057 m, 817 s, 736 m, 644 m, 599 m, 551 m, 
426 m, 412 m, 357 m, 321 m, 296 m, 225 m, 156 
m, 87 m. 
Could not be obtained 
[Ag(HL)(L)]∙H2O 3332 m,br, 3094 m,br, 2930 w,br, 1607 m, 1523 m, 
1450 m, 1418 m, 1336 s, 1283 s, 1176 m, 1115 m, 
1091 m, 877 m, 815 s, 732 m, 692 w, 623 m, 573 
w, 541 m, 433 m, 377 m, 298 m, 239 m, 183 m, 
159 m, 142 s, 125 m, 74 m 
Could not be obtained 
[Cd(HL)(L)Cl]∙H2O 3350 m, 3084 w, 2866 w, 1626 m, 1601 m, 1524 s, 
1477 m, 1436 m, 1331 s, 1285 m, 1258 m, 1229 m, 
1143 m, 1093 m, 1066 m, 883 m, 818 m, 732 m, 
693 m, 657 m, 632 m, 541 m, 474 m, 459 m, 394 
m, 355 m, 326 m, 293 w, 266 m, 207 m, 173 m, 98 
m. 
3083 m, 2823 w, 1600 s, 1521 
m, 1443 m, 1342 m, 1329 m, 
1275 m, 1228 m, 1193 m, 1127 
m, 1095 m, 1063 m, 958 w, 829 
m, 692 w, 629 w, 335 w, 238 
w, 198 w, 89 m, 69 m 
[HgCl2(HL)]∙2H2O 3382 m, 3350 m, 3076 m, 2903 w,br, 1631 m, 
1598 m, 1514 s, 1478 m, 1445 m, 1308 s, 1252 s, 
1059 m, 967 m, 906 m, 817 s, 757 m, 736 m, 692 
m, 632 m, 539 m, 467 m, 427 m, 359 m, 323 m, 
289 m, 266 m, 239 m, 211 m, 188 m, 147 m, 113 
m, 83 s. 
1632 m, 1532 m, 1445 m, 1378 
w, 1326 m, 1310 m, 1269 m, 
1245 m, 1060 m, 965 m, 867 w, 
840 w, 707 w, 634 w, 474 w, 
354 w, 145 w, 96 m 
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Table 4. 1H-NMR spectral data of the ligand and the diamagnetic complexes (the chemical shift values, H, 
ppm, with coupling constants, J, Hz, in DMSO-d6). 
 
Compound 
The benzimidazole protons The phenolic protons 
H4 H6 H7 NH H3’ H5’ H6’ OH 
HL 8.51  
s,br 
8.14 dd 
J=8.9, 1.5 
7.78 d 
J=8.8 
13.41 
s,br 
8.29 d 
J=2.2 
7.55 dd 
J=8.8, 2.4 
7.04 d 
J=8.9 
12.37 
s,br 
[Pd(HL)2Cl2] 8.60 
s,br 
8.18  
d,br 
7.96  
s,br 
12.46 
s,br 
8.43 d 
J=2.0 
7.58 dd 
J=8.8,2.4 
7.12 d 
J=8.8 
--- 
[Ag(HL)(L)]∙H2O 8.69 
s 
8.24 d 
J=8.3 
7.55 d 
J=8.3 
10.98 
s,br 
7.53 
s 
6.98 d 
J=8.8 
6.71 d 
J=8.8 
10.20 
s,br 
[Cd(HL)(L)Cl]∙H2O 8.46  
s 
8.10 dd 
J=8.8,2.0 
7.76 d 
J=8.8 
13.24 
s,br 
8.23 d 
J=2.4  
7.52 dd 
J=8.8, 2.4 
7.01 d 
J=8.8 
12.93 
s,br 
[HgCl2(HL)]∙2H2O 8.48 d 
J=1.5 
8.13 dd 
J=8.8, 2.0 
7.78 d 
J=8.8 
-- 
8.25 d 
J=2.4 
7.54 dd 
J=8.8, 2.4 
7.02 d 
J=8.8 
-- 
 
The proton H4, neighboring to the nitro group, is observed at 8.51 ppm and it appears at the 
8.468.69 ppm range at the complexes (Table 4). The OH proton of Ag(I) complex shows a 
different behavior by appearing at higher field according to the other complexes. This may be 
relevant with a different coordination of the Ag(I) complex, namely non-chelate structure. 
 
Fluorescence spectroscopy 
 
Excitation and emission spectra of the compounds were obtained in ethanol at room temperature 
(excitation wavelength: 354 nm; concentration: ~104 M). The emission spectral data are 
presented in Table 5. The fluorescence spectra of HL and its Hg(II), Cd(II), Ag(I), Fe(III) and 
Mn(II) complexes are shown in Figure 5.  
It was reported that 2-(2’-hydroxyphenyl)benzimidazole (HPBI) and its derivatives can 
undergo an excited-state intramolecular proton transfer (ESIPT) from the acidic (hydroxyl 
proton) to the basic site (aromatic nitrogen) when photoexcitation changes their charge density 
distribution [44–46]. In the ground state, the most stable form of HPBI is usually the enol form. 
However, in the first excited singlet state, in which the hydroxyl group is much more acidic and 
the nitrogen much more basic than in the ground state, the most stable structure is usually the 
keto tautomer. As a result, excitation of the enol form of HPBI tends to be followed by 
transformation to the keto form in the excited state via ESIPT reaction [46]. 
The ligand (HL) shows only a strong emission at 460 nm. All the complexes have 
fluorescence characteristic and considerable changes are observed in the fluorescence spectra of 
the complexes according to the ligand. The Cd(II) complex exhibited triple fluorescence and 
Ni(II), Cu(II), Ru(III), Pd(II) and Hg(II) complexes showed dual fluorescence while the 
uncomplexed ligand gave only single fluorescence at 460 nm. A blue shift is observed at Cu(II) 
and Ru(III) complexes whereas the other complexes red-shifted with respect to HL. Intensity of 
fluorescence generally decreases in the complexes, however in Co(II) and Fe(III) complexes it is 
almost same with the ligand, and increasing is observed at Mn(II) and Hg(II) complexes. The 
keto structure turned into the enol form as a consequence of complexation. And this change will 
affect the fluorescence characteristics of the complexes with respect to HL significantly. It is 
observed that all of the compounds have been emitting fluorescence in the visible region. 
Especially, dual fluorescence of Ru(III), Ni(II), Pd(II), Cu(II), Cd(II) and Hg(II) complexes is 
interesting. Thus, these compounds have potential applications as a luminescent material in 
light-emitting devices. 
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Figure 5. The fluorescence spectra of 
complexes in ethanol. 
 
Table 5. UV-Visible and emission maximum wavelengths (nm) of the compounds (in ethanol, ~10
 
Compound UV-visible data*
HL 230 m, 268 m, 342 sh, 349 m
[Mn(L)2(H2O)]∙H2O 232 m, 267 m, 350 m,br
[Fe(L)2(OH)(H2O)]∙2H2O 232 m, 284 m, 342 m,br, 549 m,vbr
[Ru(L)2(DMSO)2Cl]∙4H2O 247 m, 291 sh, 347 m,br, 510 sh, 581 m,br
[Co(HL)Cl2(H2O)2]∙2H2O 227 m, 336 sh, 264 m, 347 m,br, 600 w,br, 661 w,br
[Ni(HL)Cl2(H2O)2]∙4H2O 232 m, 261 sh, 266 m, 338 sh, 353 m  
[Pd(HL)2Cl2] 249 m, 320 m,br, 415 w,br
[Cu(L)2(EtOH)2]∙H2O 237 m, 263 m, 352 sh, 399 m,br, 
[Ag(HL)(L)]∙H2O 230 m, 266 m, 349 m
[Cd(HL)(L)Cl]∙H2O 228 m, 270 m,
[HgCl2(HL)]∙2H2O 229, 267 m, 347 m,br
* vbr: very broad, sh: shoulder, s: strong, m: medium, w: weak, br: broad
UV-visible spectroscopy 
The UV-visible absorption spectra of the compounds were obtained in methanol at room 
temperature. The UV-visible spectral data are given in Table 5. The UV
compounds are shown in Figure 6. 
bands in the 200–400 nm region, which can be assigned to the 
transitions. The bands below 250 nm are due to the 
intense intra-ligand absorption bands in the 250
aromatic rings are observed in the 250
bond are in between 300 and 350 nm [47]
help in the present case at the visible region, 
charge-transfer transition bands. The very broad bands at 581, 415 and 549 nm for Ru(III), 
Pd(II) and Fe(III) complexes, respectively, can be attributed to LMCT (ligand to metal charge 
transfer) transitions. The cobalt complex, [Co(
at 600 nm (16667 cm−1), 661 nm (15129 cm
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HL and Hg(II), Cd(II), Ag(I), Fe(III) and Mn(II) 
4 M)
 Emission maximum* 
 460 s 
 469 s 
 493 s 
 394 w, 457 m 
 469 s 
 394 w, 460 m 
 394 w, 474 w,br 
 394 w, 452 w,br 
 492 m,vbr 
 351 m 397 w, 459 m,vbr, 547 w,vbr
 397, 465 s 
. 
-visible spectra of the 
The electronic spectra of the compounds exhibit intense 
n→σ*, n→* and 
n→σ* transitions. The compounds exhibit 
–350 nm region. The →* transitions of the 
–300 nm region whereas the →* transitions of the C=N 
. The electronic spectra of the complexes are of little 
since the d→d transitions are masked by the strong 
HL)Cl2(H2O)2]∙2H2O, exhibited two weak bands 
−1) which may be assigned to 4T1g(F)→
4T2g(F) (
 461
. 
 
→* 
ν1) 
462
and 4T1g(F)→
4T1g(P) (ν3) transitions, respectively, and these are suggestive of octahedral 
geometry around the cobalt(II) ions
 
Figure 6. The UV-visible spectra of the ligand and complexes in ethanol. 
 
Antimicrobial activity 
 
The results concerning in vitro
values are presented in Table 6. 
Zn(NO3)2 complexes were reported in previous studies [20, 21]. 
activity on S. aureus and S. 
antibacterial activity of hydrochloride form of 
µg/mL, a remarkable value. It was also report
was also effective on these two bacteria although weaker compared to the 
Actually six bacteria and one fungus 
studied in the antimicrobial activity tests. It is considerable (and expected) result that Ag(I) and 
Hg(II) complexes show strong antimicrobial activity against to all the microorganisms. In 
addition, the Ag(I) complex shows prominent activity on 
values are 39 and 19.5 µg/mL, respectively
any activity towards to these two microorganisms. This can be considered one of the most 
important results of this study.
It is also observed that the Pd(II) and Cd(II) complexes are strongly and selectively effective 
on S. aureus and C. albicans 
complexes  generally exhibited activity towards 
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 [48, 49].  
 
 
 antimicrobial activity of the complexes together with the MIC 
Antimicrobial activity of HL and its Fe(NO3)3, Cu(NO3
HL showed considerable 
epidermidis as 2.4 and 19.5 µg/mL, respectively. In addition, 
HL (HL∙HCl) toward S. epidermidis was 2.4 
ed that the Zn(II), Fe(III) and Cu(II) complexes 
HL ligand [20, 21].
each with multiple, fresh clinical isolates, have been 
P. mirabilis and C. albicans 
) whereas AgNO3 and the ligand itself do not show 
 
(Table 6). The other complexes  except the Co(II) and Ru(III) 
S. aureus and S. epidermidis that they are 
)2 and 
 
(MIC 
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Gram positive bacteria. The Ni(II) complex is more effective on S. epidermidis (MIC: 9.75 
µg/mL) than the ligand (MIC: 19.5 µg/mL). The results of our study indicate that the ligand and 
most of the complexes have the potential to generate novel metabolites, by displaying high 
affinities towards some of the receptors. The superior antimicrobial activities of the complexes 
mentioned above against S. aureus, S. epidermidis and C. albicans are considered to be valuable 
contribution to the researches on metal-based drugs field and encourage working further 
investigation on these compounds. 
Table 6. In vitro antimicrobial activity of the compounds (MIC, µg/mL). 
Compound 
M i c r o o r g a n i s m s 
Saa Sea Ecb Kpb Pab Pmb Ca 
HL* 2.4 19.5  c     
HL∙HCl* 2.4 2.4      
[Zn(L)2]∙2H2O* 19.5 156      
[Fe(L)2(H2O)2](NO3) ∙3H2O* 9.8 39      
[Cu(L)2] ∙2H2O* 19.5 39      
[Mn(L)2(H2O)]∙H2O 4.9       
[Fe(L)2(OH)(H2O)]∙2H2O 4.9       
[Ru(L)2(DMSO)2Cl]∙4H2O        
[Co(HL)Cl2(H2O)2]∙2H2O        
[Ni(HL)Cl2(H2O)2]∙4H2O 19.5       
[Pd(HL)2Cl2] 4.9      78 
[Cu(L)2(EtOH)2]∙H2O 4.9       
[Ag(HL)(L)]∙H2O 4.9 39 39 156 39 39 19.5 
[Cd(HL)(L)Cl]∙H2O 4.9      39 
[HgCl2(HL)]∙2H2O 4.9 4.9 4.9 4.9 4.9 4.9 39 
MnCl2∙6H2O        
FeCl3∙6H2O        
CoCl2∙6H2O        
NiCl2∙6H2O        
CuCl2∙2H2O        
Ru(DMSO)4Cl2        
PdCl2        
AgNO3 9.8 4.9 4.9 4.9 4.9   
CdCl2∙H2O        
HgCl2∙H2O  0.65 0.65 1.3 0.49 10.4 1.30 2.6 
Ciprofloxacin 0.25 0.0625 0.0156 0.0078 1.0 0.0156  
Fluconazole       1.0 
*Taken from literatures 20 and 21. Sa Staphylococcus aureus ATCC 6538; Se Staphylococcus epidermidis ATCC 
12228; Ec Escherichia coli ATCC 8739; Kp Klebsiella pneumoniae ATCC 4352; Pa Pseudomonas aeruginosa 
ATCC 1539     Pm Proteus mirabilis ATCC 14153; Ca Candida albicans ATCC 10231. aGram positive;  bGram 
negative; c,  : No antimicrobial effect at 5000 µg/mL and lower dilutions. 
CONCLUSION 
In the present study, MnCl2, FeCl3, CoCl2, NiCl2, CuCl2, Ru(DMSO)4Cl2, PdCl2, AgNO3, CdCl2 
and HgCl2 complexes of HL were synthesized and characterized by using analytical and 
spectroscopic techniques such as molar conductivity, magnetic moment, TGA, UV-Vis, FT-IR, 
FT-Raman, NMR and fluorescence spectroscopy. Their antibacterial and antifungal activities 
were evaluated by the disk diffusion method against six bacteria and C. albicans as yeast. It was 
observed that most of the complexes exhibited considerable activity on S. aureus especially. The 
Hg(II) and Ag(I) complexes were found to have superior activity toward all of the 
microorganisms whereas the Pd(II) and Cd(II) complexes showed considerably antimicrobial 
effect on S. aureus and C. albicans selectively. 
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